
In vitro liver models in drug discovery: Main models, advantages and use cases
In vitro liver models are central to drug discovery and toxicology, enabling controlled evaluation of metabolism,

In vitro liver models are central to drug discovery and toxicology, enabling controlled evaluation of metabolism,

Liver disease and drug-induced liver injury remain critical challenges in medicine and pharmaceutical development, demanding models

Re-Engineering the Liver Microenvironment In the first article of this series, we discussed the limitations of

The liver organoid is transforming how researchers approach drug discovery and safety testing. As miniature, three-dimensional

Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty

Breast cancer remains the most common malignancy in women worldwide, and progress in treatment increasingly depends

Breast cancer is the second cancer-related cause of death in women worldwide, therefore it is no

Introduction Microphysiological systems (MPS) are fast becoming a cornerstone of FDA-aligned non-clinical strategy, especially when paired

Introduction Organoid and artificial intelligence approaches are central to the FDA’s roadmap for reducing animal use

Introduction Adipose tissue-breast cancer crosstalk is emerging as a key driver of tumor initiation, progression, and